| References |
| 1 |
ClinicalTrials.gov (NCT01985165) A Phase 4 Study of Imrecoxib in Treatment of Knee Osteoarthritis.
|
| 2 |
Lack of effect of Imrecoxib, an innovative and moderate COX-2 inhibitor, on pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers. Sci Rep. 2019 Oct 31;9(1):15774.
|
| 3 |
Differences in the In Vivo and In Vitro Metabolism of Imrecoxib in Humans: Formation of the Rate-Limiting Aldehyde Intermediate Drug Metab Dispos. 2018 Sep;46(9):1320-1328. doi: 10.1124/dmd.118.081182.
|
| 4 |
Comparative Pharmacokinetics and Safety of Imrecoxib, a Novel Selective Cyclooxygenase-2 Inhibitor, in Elderly Healthy Subjects. Drug Des Devel Ther. 2022 Nov 8;16:3865-3876. doi: 10.2147/DDDT.S387508.
|
| 5 |
Metabolism and excretion of imrecoxib in rat Xenobiotica. 2006 May;36(5):441-55. doi: 10.1080/00498250600595524.
|
| 6 |
Exposures to estradiol, ethinylestradiol and octylphenol affect survival and growth of Rana pipiens and Rana sylvatica tadpoles J Toxicol Environ Health A. 2006 Aug;69(16):1555-69. doi: 10.1080/15287390500470759.
|
| 7 |
Database composition can affect the structure-activity relationship prediction J Toxicol Environ Health A. 2006 Aug;69(16):1527-40. doi: 10.1080/15287390500468746.
|
| 8 |
Ozone exposure impairs antigen-specific immunity but activates IL-7-induced proliferation of CD4-CD8- thymocytes in BALB/c mice J Toxicol Environ Health A. 2006 Aug;69(16):1511-26. doi: 10.1080/15287390500468696.
|
| 9 |
Changes in the growth, but not the survival, of American kestrels (Falco sparverius) exposed to environmentally relevant polybrominated diphenyl ethers J Toxicol Environ Health A. 2006 Aug;69(16):1541-54. doi: 10.1080/15287390500468753.
|
